Cargando…

Biomarkers and Surrogate Endpoints: Lessons Learned From Glaucoma

With the recent progress in imaging technologies for assessment of structural damage in glaucoma, a debate has emerged on whether these measurements can be used as valid surrogate endpoints in clinical trials evaluating new therapies for the disease. A discussion of surrogates should be grounded on...

Descripción completa

Detalles Bibliográficos
Autor principal:	Medeiros, Felipe A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Association for Research in Vision and Ophthalmology 2017
Materias:	Special Issue
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455347/ https://www.ncbi.nlm.nih.gov/pubmed/28475699 http://dx.doi.org/10.1167/iovs.17-21987

Ejemplares similares

A Review of Deep Learning for Screening, Diagnosis, and Detection of Glaucoma Progression
por: Thompson, Atalie C., et al.
Publicado: (2020)

Bayesian meta‐analytical methods to incorporate multiple surrogate endpoints in drug development process
por: Bujkiewicz, Sylwia, et al.
Publicado: (2015)

The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research
por: Roy, Neeta S., et al.
Publicado: (2017)

Artificial Intelligence Mapping of Structure to Function in Glaucoma
por: Mariottoni, Eduardo B., et al.
Publicado: (2020)

Surrogate endpoints.
por: Ellenberg, S. S.
Publicado: (1993)

Overview of Biomarkers and Surrogate Endpoints in Drug Development
por: Wagner, John A.
Publicado: (2002)

Surrogate Endpoints in Medicine
por: Srivastava, Sudhir, et al.
Publicado: (2002)

Effects of Study Population, Labeling and Training on Glaucoma Detection Using Deep Learning Algorithms
por: Christopher, Mark, et al.
Publicado: (2020)

The evaluation of surrogate endpoints
por: Burzykowski, Tomasz, et al.
Publicado: (2005)

Artificial Intelligence Algorithms to Diagnose Glaucoma and Detect Glaucoma Progression: Translation to Clinical Practice
por: Mursch-Edlmayr, Anna S., et al.
Publicado: (2020)

A 3D Deep Learning System for Detecting Referable Glaucoma Using Full OCT Macular Cube Scans
por: Russakoff, Daniel B., et al.
Publicado: (2020)

The Potential of Human Stem Cells for the Study and Treatment of Glaucoma
por: Chamling, Xitiz, et al.
Publicado: (2016)

First do no harm: surrogate endpoints and the lesson of β-agonists in acute lung injury
por: Lakshminarayana, Pradeep H, et al.
Publicado: (2012)

Detection of Functional Change Using Cluster Trend Analysis in Glaucoma
por: Gardiner, Stuart K., et al.
Publicado: (2017)

Biomarkers and Surrogate Endpoints: How and When might They Impact Drug Development?
por: Lathia, Chetan D.
Publicado: (2002)

Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers
por: Manyara, Anthony Muchai, et al.
Publicado: (2022)

The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
por: Sargent, Daniel J., et al.
Publicado: (2017)

OCTA Multilayer and Multisector Peripapillary Microvascular Modeling for Diagnosing and Staging of Glaucoma
por: Andrade De Jesus, Danilo, et al.
Publicado: (2020)

Is critical care ready for an economic surrogate endpoint?
por: Wilcox, M Elizabeth, et al.
Publicado: (2015)

Surrogate endpoints in early prostate cancer research
por: Williams, Scott
Publicado: (2018)

Surrogate endpoints… Uncommon for a common man!
por: Kumar, Ashish
Publicado: (2019)

Surrogate Endpoints for Late Kidney Transplantation Failure
por: Naesens, Maarten, et al.
Publicado: (2022)

Fibrosis: Shared Lessons From the Lens and Cornea
por: Menko, A. Sue, et al.
Publicado: (2019)

Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions
por: Ciani, Oriana, et al.
Publicado: (2022)

Abstracts of the NIH-FDA Conference “Biomarkers and Surrogate Endpoints: Advancing Clinical Research and Applications”
Publicado: (1998)

Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers
por: Morel, Alix, et al.
Publicado: (2021)

Effects of glaucoma on detection and discrimination of image blur
por: Bham, Habiba A, et al.
Publicado: (2022)

The special issue on cancer and evolution: Lessons learned
por: DeGregori, James
Publicado: (2020)

Lessons from morpholino-based screening in zebrafish
por: Bedell, Victoria M., et al.
Publicado: (2011)

Sample Size Requirements of Glaucoma Clinical Trials When Using Combined Optical Coherence Tomography and Visual Field Endpoints
por: Wu, Zhichao, et al.
Publicado: (2019)

Statistical evaluation of surrogate endpoints: a systematic review
por: Ensor, Hannah, et al.
Publicado: (2013)

Bivariate network meta‐analysis for surrogate endpoint evaluation
por: Bujkiewicz, Sylwia, et al.
Publicado: (2019)

Surrogate endpoints in trials: a call for better reporting
por: Ciani, Oriana, et al.
Publicado: (2022)

Biomarker changes as surrogate endpoints in early‐phase trials in heart failure with reduced ejection fraction
por: Savarese, Gianluigi, et al.
Publicado: (2022)

COVID-19 severity detection using machine learning techniques from CT-images
por: Aswathy, A. L., et al.
Publicado: (2022)

Binary surrogate endpoints in clinical trials from the perspective of case definitions
por: HAHN, ANDREAS, et al.
Publicado: (2021)

Cervical Acid Phosphatase: A Biomarker of Cervical Dysplasia and a Potential Surrogate Endpoint for Colposcopy
por: Markovic, Olivera, et al.
Publicado: (2004)

Simple Methods for Evaluating 4 Types of Biomarkers: Surrogate Endpoint, Prognostic, Predictive, and Cancer Screening
por: Baker, Stuart G, et al.
Publicado: (2020)

Surrogate endpoints and competing risk of death in cardiac arrest research
por: McCredie, Victoria A., et al.
Publicado: (2016)

Introduction to Machine Learning, Neural Networks, and Deep Learning
por: Choi, Rene Y., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h17j3fe9j67f88rur9aol1c1vl